News Cara Therapeutics, Inc. Berne S.E.

Equities

69C

US1407551092

Delayed Berne S.E. Other stock markets			5-day change	1st Jan Change
- ^CHF	-.--%		-.--%	-.--%

06-20	Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday	MT
06-18	Cara Therapeutics to Idle 70% Workforce, Explore Alternatives After Scrapping Notalgia Paresthetica Program	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday	06-20	MT
Cara Therapeutics : Costs Associated with Exit/Disposal Form 8 K	06-19	PU
Cara Therapeutics to Idle 70% Workforce, Explore Alternatives After Scrapping Notalgia Paresthetica Program	06-18	MT
Needham Downgrades Cara Therapeutics to Hold From Buy	06-13	MT
HC Wainwright Downgrades Cara Therapeutics to Neutral From Buy	06-13	MT
Stifel Downgrades Cara Therapeutics to Hold From Buy, Adjusts Price Target to $1 From $6	06-13	MT
Canaccord Genuity Downgrades Cara Therapeutics to Hold From Buy, Adjusts Price Target to $1 From $10	06-13	MT
Cara Therapeutics discontinues neurological condition study as drug fails	06-12	RE
Cara Therapeutics, Inc. Announces Outcome from Dose-Finding Part A of the Kourage-1 Study	06-12	CI
Cara Therapeutics Discontinues NP Program After Drug Study Fails to Show Clinical Benefit -- Shares Drop	06-12	MT
Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica	06-12	GL
Cara Therapeutics, Inc. Explores Strategic Alternatives	06-11	CI
Cara: Q1 Earnings Snapshot	05-13	AQ
Earnings Flash (CARA) CARA THERAPEUTICS Posts Q1 Revenue $2.1M, vs. Street Est of $1.7M	05-13	MT
Cara Therapeutics Reports First Quarter 2024 Financial Results	05-13	GL
Cara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-13	CI
Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024	05-06	GL
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference	04-02	GL
Cara Therapeutics, Inc. Announces Resignation of Dr. Joana Goncalves as Chief Medical Officer, Effective April 16, 2024	03-22	CI
Cara Therapeutics to Host Notalgia Paresthetica Virtual KOL Event on Wednesday, March 27, 2024	03-08	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Cara Therapeutics, Inc. Berne S.E.

Equities

69C

US1407551092

Summary

Filters